loadpatents
name:-0.025864839553833
name:-0.010450839996338
name:-0.0034689903259277
Violette; Shelia M. Patent Filings

Violette; Shelia M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Violette; Shelia M..The latest application filed is for "biomarkers for use in integrin therapy applications".

Company Profile
2.10.19
  • Violette; Shelia M. - Lexington MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biomarkers For Use In Integrin Therapy Applications
App 20220049301 - Violette; Shelia M. ;   et al.
2022-02-17
Biomarkers For Use In Integrin Therapy Applications
App 20200248257 - Kind Code
2020-08-06
Anti-alpha V beta 6 antibodies and uses thereof
Grant 10,035,859 - Violette , et al. July 31, 2
2018-07-31
Anti-alpha V beta 6 antibodies and uses thereof
Grant 10,035,860 - Violette , et al. July 31, 2
2018-07-31
Humanized Anti-alpha V Beta 5 Antibodies And Uses Thereof
App 20170362324 - Cameron; Thomas Owen ;   et al.
2017-12-21
Anti-.alpha..sub..nu..beta..sub.6 antibodies
Grant 9,745,376 - Violette , et al. August 29, 2
2017-08-29
Anti-alpha V Beta 6 Antibodies And Uses Thereof
App 20160031992 - Violette; Shelia M. ;   et al.
2016-02-04
Anti-alpha V Beta 6 Antibodies And Uses Thereof
App 20160017042 - Violette; Shelia M. ;   et al.
2016-01-21
Treatment And Prevention Of Acute Kidney Injury Using Anti-alpha V Beta 5 Antibodies
App 20160017041 - Violette; Shelia M. ;   et al.
2016-01-21
Anti-alpha(v)beta(6) Antibodies
App 20150140609 - Violette; Shelia M. ;   et al.
2015-05-21
Anti-.alpha..sub..nu..beta..sub.6 antibodies and uses thereof
Grant 8,992,924 - Violette , et al. March 31, 2
2015-03-31
Biomarkers For Use In Integrin Therapy Applications
App 20150086570 - Violette; Shelia M. ;   et al.
2015-03-26
Anti-Alpha(v)Beta(6) Antibodies and Uses Thereof
App 20140294809 - Violette; Shelia M. ;   et al.
2014-10-02
Compositions and methods for inhibiting growth of SMAD4-deficient cancers
Grant RE44,681 - Violette , et al. December 31, 2
2013-12-31
Anti-alpha V Beta 6 Antibodies
App 20120251532 - Violette; Shelia M. ;   et al.
2012-10-04
Anti-.alpha..sub.v.beta..sub.6 antibodies
Grant 8,153,126 - Violette , et al. April 10, 2
2012-04-10
Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
App 20120027754 - Sheppard; Dean ;   et al.
2012-02-02
Anti-Alpha v Beta 6 Antibodies and Uses Thereof
App 20110305629 - Violette; Shelia M. ;   et al.
2011-12-15
Compositions and Methods for Inhibiting Growth of SMAD-4 Deficient Cancers
App 20110293512 - Violette; Shelia M. ;   et al.
2011-12-01
Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
App 20110287007 - Sheppard; Dean ;   et al.
2011-11-24
Anti-.alpha..sub.v.beta..sub.6 antibodies and uses thereof
Grant 7,943,742 - Violette , et al. May 17, 2
2011-05-17
Compositions and methods for inhibiting growth of smad4-deficient cancers
Grant 7,927,590 - Violette , et al. April 19, 2
2011-04-19
Anti-Alpha V Beta 6 Antibodies
App 20090186036 - Violette; Shelia M. ;   et al.
2009-07-23
TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6
App 20090028853 - SHEPPARD; Dean ;   et al.
2009-01-29
Compositions and methods for inhibiting growth of smad4-deficient cancers
App 20080317667 - Violette; Shelia M. ;   et al.
2008-12-25
Anti-.alpha..sub.v.beta..sub.6 antibodies
Grant 7,465,449 - Violette , et al. December 16, 2
2008-12-16
Anti-alpha(v)beta(6) antibodies and uses thereof
App 20080286269 - Violette; Shelia M. ;   et al.
2008-11-20
Anti-alphavbeta6 antibodies
App 20050255102 - Violette, Shelia M. ;   et al.
2005-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed